Apixaban: Safety, usefulness and practical details of laboratory monitoring

Jonathan Douxfils, François Mullier, Jean-François Classen, Justine Baudar, Sébastien Walbrecq, Christian Chatelain, Bernard Chatelain, Jean-Michel Dogne

Research output: Contribution in Book/Catalog/Report/Conference proceedingConference contribution

Original languageEnglish
Title of host publicationJournal of Thrombosis and Haemostasis. 2013 Jul;11 Suppl 2:1-1322
Publication statusPublished - 2013
EventXXIV Congress of the International Society of Thrombosis and Haemostasis - Amsterdam, Netherlands
Duration: 29 Jun 20134 Jul 2013

Conference

ConferenceXXIV Congress of the International Society of Thrombosis and Haemostasis
CountryNetherlands
CityAmsterdam
Period29/06/134/07/13

Student Theses

Evaluation of thrombotic and/or bleeding risks associated with anticoagulotherapy.

Author: Douxfils, J., 24 Oct 2015

Supervisor: Dogne, J. (Supervisor), Mullier, F. (Supervisor), Masereel, B. (President), Chatelain, B. (Jury), Chatelain, C. (External person) (Jury), Verhamme, P. (External person) (Jury), TEN CATE, H. (External person) (Jury) & Ageno, W. (External person) (Jury)

Student thesis: Doc typesDoctor of Biomedical and Pharmaceutical Sciences

Cite this

Douxfils, J., Mullier, F., Classen, J-F., Baudar, J., Walbrecq, S., Chatelain, C., Chatelain, B., & Dogne, J-M. (2013). Apixaban: Safety, usefulness and practical details of laboratory monitoring. In Journal of Thrombosis and Haemostasis. 2013 Jul;11 Suppl 2:1-1322 http://www.eventure-online.com/eventure/publicAbstractView.do?id=216097&congressId=6839